Robotic Myomectomy: A UK Patient's Guide to da Vinci Fibroid Surgery

Robotic myomectomy uses a sophisticated surgical platform — most commonly the da Vinci system — to assist the surgeon in removing uterine fibroids through very small keyhole incisions. It is important to understand that the robot does not operate autonomously. The surgeon is in complete control at all times, sitting at a console a few feet from the patient.

The system translates the surgeon's hand movements into extremely precise micro-movements of robotic arms, which hold miniature instruments inserted into the abdomen through 8–12 mm ports. One of the instruments is a high-definition 3D camera, giving the surgeon a magnified, immersive view of the operating field — far better than the 2D view of standard laparoscopy.

The main clinical advantage over conventional laparoscopy is the 'wristed' instruments. Unlike straight laparoscopic tools, robotic instruments bend and rotate through a full range of motion, which is critical for the delicate suturing required to close the uterus properly after a fibroid is removed.

Compared with traditional open myomectomy — which requires a bikini-line or vertical incision of 10–20 cm — the difference is dramatic. Robotic surgery uses 3–5 small incisions, resulting in far less pain, minimal blood loss, no visible scar, and a much faster return to normal activity.

Compared with standard laparoscopic myomectomy, robotics is a meaningful step forward for complex cases. The 3D vision, tremor filtering and wristed instruments allow multi-layered uterine repair that would be technically very difficult with straight laparoscopic tools. This matters most when the fibroids are large, deep, multiple, or in awkward positions where standard laparoscopy would struggle to reconstruct the uterus reliably.

For simpler cases with one or two accessible fibroids, standard laparoscopy achieves equivalent outcomes at lower cost. Robotics really earns its place when the alternative would otherwise have been open surgery. See our guide comparing all myomectomy techniques for a fuller picture.

Robotic myomectomy is ideally suited to women who need a fibroid removed but want to preserve the uterus, and whose fibroids are too large or numerous for straightforward laparoscopy but who would otherwise face open surgery.

• Women planning future pregnancy — the precise uterine repair is important for reducing rupture risk in labour.
• Fibroids between 5 and 12 cm, particularly intramural (in the uterine wall).
• Multiple fibroids (typically up to 5–6) in different locations.
• Fibroids in difficult positions — posterior wall, close to the fallopian tubes, or near the cervix.
• Previous abdominal surgery causing adhesions.
• Higher BMI, where standard laparoscopy is technically harder.

Robotics is not always the right answer. Very small, straightforward fibroids can be removed just as well by standard laparoscopy or hysteroscopy at lower cost. Very large fibroids (over 15 cm) or uteruses larger than 20 weeks gestation size may still require open surgery to be safe. Submucosal fibroids growing inside the cavity are usually best removed by hysteroscopy through the vagina — no abdominal incisions at all.

You will be admitted on the day of surgery and given a general anaesthetic. Three to five small ports are placed in the lower abdomen, and the robotic arms docked. The surgeon operates from a console in the same theatre, viewing the operating field in 3D.

Each fibroid is carefully identified, dissected out of the uterine wall, and removed. Bleeding is controlled with a mixture of energy devices and careful suturing. The uterine defect is then closed in multiple layers using continuous or interrupted stitches — this is where the wristed robotic instruments really earn their place, because a strong, multi-layer closure is what makes future pregnancy safer.

The fibroid tissue is then removed from the abdomen through one of the port sites using a contained retrieval bag. Total operating time is usually 90 minutes to 3 hours depending on complexity.

Most patients stay in hospital for one night. You will be up walking within a few hours of surgery. Pain is controlled with a combination of paracetamol, anti-inflammatories and short-course opioids — the small incisions mean that pain is genuinely limited for most people by day 3–5.

• Days 1–3: hospital and home, gentle walking, no lifting.
• Week 1: driving usually safe by day 7–10 once no longer on strong pain relief.
• Weeks 2–3: back to desk-based work.
• Weeks 4–6: gradual return to gym and exercise.
• 6 weeks: usually cleared for full activity, including intercourse.
• 3 months: usually the earliest safe point to start trying to conceive, though your surgeon may recommend longer if the uterine repair was extensive.

Robotic myomectomy is available on the NHS but access is uneven and often restricted to major specialist centres in London, Manchester, Oxford and Cambridge. Referral usually requires a gynaecology consultant to specifically request the robotic pathway, and waiting times can be significant.

In the private sector in the UK, robotic myomectomy is more widely available at teaching hospitals and larger private groups, with typical costs of £14,000–£22,000. Increasingly, UK patients travel to specialist centres in Istanbul for combined care — MRI, consultation, robotic surgery and follow-up as a single package — often at less than half the UK private cost. Read our patient guide on fibroid surgery in Turkey for a full comparison of pathways.

The main risks are similar to any myomectomy: bleeding, infection, injury to nearby organs (bladder, bowel, ureters — rare), adhesions, and conversion to open surgery if the operation cannot be completed safely by robotics (about 2–5% of cases).

The most important long-term consideration is the risk of uterine rupture in a future pregnancy — the reason a strong, multi-layer closure matters. Reported rupture rates after robotic myomectomy are broadly similar to open myomectomy (well under 1%), and considerably lower than after ablative techniques. Recurrence of new fibroids is around 10–25% over 5–10 years, but only a minority of these need further surgery.